A promising new alternative for the rapid reversal of warfarin coagulopathy in traumatic intracranial hemorrhage

被引:24
作者
Safaoui, Marian N. [1 ]
Aazami, Roshanak [1 ]
Hotz, Heidi [1 ]
Wilson, Matthew T. [1 ]
Margulies, Daniel R. [1 ]
机构
[1] Cedars Sinai Med Ctr, Dept Surg, Los Angeles, CA 90048 USA
关键词
Factor IX complex; Prothrombin complex concentrate; Traumatic intracranial hemorrhage; Warfarin reversal; Warfarin-induced coagulopathy; PROTHROMBIN COMPLEX CONCENTRATE; RECOMBINANT FACTOR VIIA; ACTIVATED FACTOR-VII; ORAL ANTICOAGULANT-THERAPY; INTRACEREBRAL HEMORRHAGE; FACTOR-IX; URGENT REVERSAL; EFFICACY; SAFETY; BERIPLEX;
D O I
10.1016/j.amjsurg.2008.04.003
中图分类号
R61 [外科手术学];
学科分类号
摘要
BACKGROUND: Internationally, Factor IX complex (FIX complex) has been used to correct warfarin-induced coagulopathy. We present our experience with 28 patients using FIX complex. METHODS: A retrospective chart review was conducted between November 2002 and July 2006 on patients with warfarin-induced coagulopathy. We recorded the dose and timing of FIX complex, serial international normalized ratios (INRs), early adverse events, and patient outcome. RESULTS: Twenty-eight patients met criteria. The mean INR on admission was 5.1, and after FIX complex infusion was reduced significantly to 1.9 (P = .008). Eleven patients had a repeat INR drawn within 30 minutes after FIX complex infusion. The mean time to correction was 13.5 minutes. There were no early thrombotic events or allergic reactions. CONCLUSIONS: FIX complex results in an immediate reversal of coagulopathy within 15 minutes after administration. Its use should be considered as an alternative treatment to fresh-frozen plasma and recombinant Factor VIIa. Prospective randomized trials are needed to confirm these findings. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:785 / 790
页数:6
相关论文
共 31 条
  • [1] Treatment of warfarin-associated intracerebral hemorrhage:: Literature review and expert opinion
    Aguilar, Maria I.
    Hart, Robert G.
    Kase, Carlos S.
    Freeman, William D.
    Hoeben, Maj Barbara J.
    Garcia, Rosa C.
    Ansell, Jack E.
    Mayer, Stephan A.
    Norrving, Bo
    Rosand, Jonathan
    Steiner, Thorsten
    Wijdicks, Eelco F. M.
    Yamaguchi, Takenori
    Yasaka, Masahiro
    [J]. MAYO CLINIC PROCEEDINGS, 2007, 82 (01) : 82 - 92
  • [2] Warfarin reversal: consensus guidelines on behalf of the Australasian Society of Thrombosis and Haemostasis
    Baker, RI
    Coughlin, PB
    Gallus, AS
    Harper, PL
    Salem, HH
    [J]. MEDICAL JOURNAL OF AUSTRALIA, 2004, 181 (09) : 492 - +
  • [3] Coagulopathic patients with traumatic intracranial bleeding: Defining the role of recombinant factor VIIa
    Bartal, Carmi
    Freedman, John
    Bowman, Kim
    Cusimano, Michael
    [J]. JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2007, 63 (04): : 725 - 732
  • [4] Use of factor IX complex in warfarin-related intracranial hemorrhage
    Boulis, NM
    Bobek, MP
    Schmaier, A
    Hoff, JT
    [J]. NEUROSURGERY, 1999, 45 (05) : 1113 - 1118
  • [5] Use of recombinant factor VIIa in patients with warfarin-associated intracranial hemorrhage
    Brody, DL
    Aiyagari, V
    Shackleford, AM
    Diringer, MN
    [J]. NEUROCRITICAL CARE, 2005, 2 (03) : 263 - 267
  • [6] Cartmill M, 2000, BRIT J NEUROSURG, V14, P458
  • [7] Deveras RAE, 2002, ANN INTERN MED, V137, P884, DOI 10.7326/0003-4819-137-11-200212030-00009
  • [8] Prothrombin complex concentrate versus recombinant factor VIIa for reversal of coumarin anticoagulation
    Dickneite, Gerhard
    [J]. THROMBOSIS RESEARCH, 2007, 119 (05) : 643 - 651
  • [9] Beriplex P/N reverses severe warfarin-induced overanticoagulation immediately and completely in patients presenting with major bleeding
    Evans, G
    Luddington, R
    Baglin, T
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2001, 115 (04) : 998 - 1001
  • [10] Warfarin reversal
    Hanley, JP
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 2004, 57 (11) : 1132 - 1139